Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2003
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368354A1 Modulators of chemokine receptor activity
12/10/2003EP1368346A1 Substituted benzofuran-2-carboxamides derivatives
12/10/2003EP1368344A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
12/10/2003EP1368338A1 Method of preparing lansoprazole and its intermediate
12/10/2003EP1368335A2 Novel amino dicarboxylic acid derivatives with pharmaceutical properties
12/10/2003EP1368327A1 Benzo thiadiazine matrix metalloproteinase inhibitors
12/10/2003EP1368324A1 Quinazolines as mmp-13 inhibitors
12/10/2003EP1368320A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof
12/10/2003EP1368319A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
12/10/2003EP1368318A2 Calcilytic compounds
12/10/2003EP1368317A1 Tryptase inhibitors
12/10/2003EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators
12/10/2003EP1368312A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368304A1 Prodrugs of excitatory amino acids
12/10/2003EP1368303A1 Halogen-substituted amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases
12/10/2003EP1368302A1 Novel amino dicarboxylic acid derivatives
12/10/2003EP1368301A1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases
12/10/2003EP1368300A1 Substituted amino dicarboxylic acid derivatives
12/10/2003EP1368094A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
12/10/2003EP1368063A2 Complex of modafinil and cyclodextrin
12/10/2003EP1368051A2 Urocortin-iii and uses thereof
12/10/2003EP1368048A1 Pharmaceutical composition made of cannabis extracts
12/10/2003EP1368038A1 Methods for the administration of amifostine and related compounds
12/10/2003EP1368037A2 Estrogen replacement therapy
12/10/2003EP1368027A2 Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors
12/10/2003EP1368007A1 Coating and binding agent for pharmaceutical formulations with improved storage stability
12/10/2003EP1368006A1 Novel modified released formulation
12/10/2003EP1367999A2 Water soluble and palatable complexes
12/10/2003EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
12/10/2003EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1187829B1 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
12/10/2003EP1185276B1 Isophosphoramide mustard analogs and use thereof
12/10/2003EP1163243B1 Calanolides for inhibiting btk
12/10/2003EP1091953B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
12/10/2003EP1049711B1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
12/10/2003EP1039916B1 Use of at least one fucane for the manufacture of a medicament for the treatment of periodontal pathologies
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/10/2003EP0901374B1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
12/10/2003EP0828498B1 Chemotherapeutic compositions
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003CN1461340A Method of isolating bipotent hepatic progenitor cells
12/10/2003CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using
12/10/2003CN1461308A Leucine-based motif and clostridial neurotoxins
12/10/2003CN1461304A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461303A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461299A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461209A Use of olive oil in preparation of products for oral hygiene for eliminating or reducing bacterial plaque and/or bacteria in mouth
12/10/2003CN1460521A Recombinant hepatitis B BCG vaccine combined vaccine and its preparation method
12/10/2003CN1460515A Medicine for curing constipation
12/10/2003CN1460514A Chinese medicine composite for curing chronic hepatitis B, fibrosis of liver and for curing SARS
12/10/2003CN1460508A Medicine for curing diseases of digestive system and its preparation method
12/10/2003CN1460503A Brandisia hancei soft capsule and its preparation method
12/10/2003CN1460501A Chinese medicine for curing dyspepsia
12/10/2003CN1460497A Freeze-dried powder injection for curing hepatitis, large dise transfusion medicine and its preparation method
12/10/2003CN1460491A Medicine for curing diarrhea and red and white dysentery
12/10/2003CN1460487A Propolis soft capsule and its preparation method
12/10/2003CN1460481A Medicine composition using resveratrol glucodside for curing fatty liver and its preparation method
12/10/2003CN1460477A Prpearation method of H2 receptor antagonist composite salt and its application
12/10/2003CN1460435A Liver-protecting functional food made up by using ligustrum fruit and silkworm chrysalis and its preparation method
12/10/2003CN1130355C Thienyl-, furyl-, pyrrolyl-and biphenylsulfonamides and derivatives thereof modulate activity of endothelin
12/10/2003CN1130351C 1,5-benzodiazepine derivatives
12/10/2003CN1130349C H3 receptor liqands of phenyl-alkyl-imidazoles type
12/10/2003CN1130223C Pharmaceutical formulation containing growth hormone, amino acid and non-ionic detergent
12/10/2003CN1130219C Powder for curing hepatic calculus
12/10/2003CN1130212C Medicine for treating abdominal node and its preparing method
12/10/2003CN1130210C Songzhi pill
12/10/2003CN1130204C Pharmaceutical composition with antimicrobial activty
12/10/2003CN1130198C Appliance of Ampelopsis grossedentata total flavone for curing oral ulcer
12/09/2003US6660859 Arylpiperzine derivatives are useful for treatment of anxiety, depression, hypertension, cognitive disorders, sexual dysfunction, brain trauma, memory loss, eating disorders, obesity, substance abuse, and obsessive-compulsive diseases
12/09/2003US6660839 Tumor necrosis related receptor, TR7
12/09/2003US6660771 Remedies for liver regeneration of transplanted liver
12/09/2003US6660759 4.5-diaryloxazole compounds with prostaglandin I2 (PGI2) agonistic activity
12/09/2003US6660752 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
12/09/2003US6660751 Sulfonamide derivatives as 5-HT7 receptor antagonists
12/09/2003US6660746 Cardiovascular disorders
12/09/2003US6660744 Pyrazolopyrimidines as therapeutic agents
12/09/2003US6660738 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003US6660721 Anti-HCV nucleoside derivatives
12/09/2003US6660289 Disinfecting composition based on H2O2, acids and metal ions
12/09/2003US6660259 Herpes simplex virus for treating unwanted hyperproliferative cell growth
12/09/2003US6659282 Antiinflammatory lipoxing derivatives
12/09/2003CA2202075C Analogs of keratinocyte growth factor, nucleic acids encoding such analogs, processes of making and methods of using
12/09/2003CA2123697C Novel substituted salicylic acids
12/09/2003CA2086811C 4,13-dioxabicyclo [8.2.1] tridecenone compounds process and intermediates for their preparation and pharmaceutical compositions containing them
12/04/2003WO2003100091A1 Means and methods for improved treatment using 'setrones'
12/04/2003WO2003100033A2 ANTI-αvβ6 ANTIBODIES
12/04/2003WO2003100023A2 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration
12/04/2003WO2003100008A2 Neutralizing human anti-igfr antibody
12/04/2003WO2003099874A1 Extraction of unmilled psyllium
12/04/2003WO2003099845A2 Fas peptide mimetics and uses thereof
12/04/2003WO2003099839A1 Modulators and inhibitors of fibroblast growth factor receptor 5_polypeptides and gene expression thereof.
12/04/2003WO2003099827A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099824A1 R-enantiomers of pyranoindole derivatives against hepatitis c
12/04/2003WO2003099823A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099820A1 Pyrazolo-pyrimidine aniline compounds
1 ... 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 ... 1258